(Q55058738)

English

Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

metastatic potential

1 reference

based on heuristic

inferred from title

1

object named as

Sarah K Baird

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

author name string

Laura Allan

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

Christoph Renner

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

Fiona E Scott

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

Andrew M Scott

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

publication date

21 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

Clinical & Experimental Metastasis

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

32

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

507-516

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

https://scigraph.springernature.com/pub.10.1007/s10585-015-9723-4

0 references

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies.

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

A novel protease-docking function of integrin at invadopodia

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

EMT, the cytoskeleton, and cancer cell invasion

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Signal transduction by focal adhesion kinase in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

The cytoskeleton and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Fibroblast activation protein-α promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9723-4

21 January 2018

Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted disruption of the beta1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultraviolet exposure of melanoma cells induces fibroblast activation protein-α in fibroblasts: Implications for melanoma invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of fibroblast activation protein on osteosarcoma cell lines in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of fibroblast activation protein in patients with colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of seprase in effusions from patients with epithelial ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signalling via integrins: implications for cell survival and anticancer strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25995078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10585-015-9723-4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/25995078

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55058738&oldid=1975524252"